Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

John P. Palmer; Arief A. Suriawinata; Shaofeng Yan; Darcy A. Kerr; Muhammad Z. Afzal; Keisuke Shirai

doi:10.12659/AJCR.938537

18 November 2023 : Case report USA

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Unusual or unexpected effect of treatment

John P. Palmer^1ADEF*, Arief A. Suriawinata^2BDE, Shaofeng Yan^2BDE, Darcy A. Kerr^2BDE, Muhammad Z. Afzal^1ABCE, Keisuke Shirai^1ADEF

DOI: 10.12659/AJCR.938537

Am J Case Rep 2023; 24:e938537

Authors information Article notes Copyright and License information

Background Case Reports Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 21. Case 7: (A) A lung biopsy shows metastatic melanoma with prominent nuclear pleomorphism (hematoxylin and eosin [H&E], original magnification ×200) and (B) strong SOX10 staining (immunohistochemistry, ×200). (C) Subsequent lobectomy shows metastatic melanoma with a rounded contour and a peripheral rim of uninvolved lung parenchyma (H&E, ×6).

Back to the Article

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Your Privacy